U.S. market Closed. Opens in 17 hours 50 minutes

SLGCW | SomaLogic, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-31
Revenue97.67M81.63M55.89M32.19M
Cost of Revenue43.36M33.46M22.61M49.72M
Gross Profit54.30M48.16M33.27M-17.53M
Operating Expenses230.06M121.47M67.63M33.99M
Selling, General & Admin156.62M77.97M36.88M33.42M
Research & Development73.44M43.50M30.75M32.50M
Other Operating Expenses1.95M681.00KN/AN/A
Operating Income-175.76M-73.30M-34.36M-50.96M
Other Expenses / Income65.89M-14.21M-18.66M-6.04M
Before Tax Income-109.87M-87.55M-53.02M-57.00M
Income Tax Expenses-717.00K-1.25M18.34MN/A
Net Income-109.16M-86.30M-71.35M-57.00M
Interest ExpensesN/A1.32M18.34MN/A
Basic Shares Outstanding183.99M137.16M181.16MN/A
Diluted Shares Outstanding183.99M137.16M181.16MN/A
EBITDA-175.76M-73.30M-31.53M-47.80M
EBITDA Margin-179.96%-89.80%-56.42%-148.51%
EBIT-109.87M-86.22M-34.68M-57.00M
EBIT Margin-112.50%-105.63%-62.05%-177.10%
Financial Year End2022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙